VARIOUS experimental observations suggest that brain microvasculature is under neuronal control of the central adrenergic system. In fact, morphological studies show that brain capillary endothelium is closely associated with adrenergic fibers originating from the locus coeruleus (Swanson et al., 1977) , whereas physiological data indicate that a-and /3-adrenergic receptors are involved in regulatory mechanisms of brain microvasculature. In particular, it is suggested that the two populations of receptors play an important role in mediating changes of cerebral blood flow and blood-brain barrier (BBB) permeability to molecules such as water and glucose (Raichle et al., 1975; MacKenzie et al., 1976 MacKenzie et al., a, 1976b Bates et al., 1977; Grubb et al., 1978; Schwartz, 1978; Abraham et al., 1979) . Furthermore, biochemical experiments demonstrated the presence of norepinephrine, its synthesizing and catabolizing enzymes (Lai et al., 1975) , and adrenergic receptors in cerebral microvessels. /3-Adrenergic receptors linked to adenylate cyclase in the microvessels were well characterized (Herbst et al., 1979; Nathanson and Glaser, 1979; Kobayashi et al., 1981a Kobayashi et al., , 1981b Kobayashi et al., , 1982a Kobayashi et al., , 1982b Kobayashi et al., , 1982c . The existence of a-adrenergic receptors was also reported (Peroutka et al., 1980; Kobayashi et al., 1982a) ; however, the properties of the receptors were not fully analyzed.
On the other hand, several studies indicate that hypertension affects cerebral micro vessel functions. In particular, increased BBB permeability and impairment of cerebral blood flow autoregulation have been described (Johansson, 1976; Strangaard et al., 1973 , Hatzinikolau et al., 1981 . Recently, we reported that the number of /3-receptors located in the cerebral microvessels is decreased by about 30% in both genetic and experimental hypertensive rats (Magnoni et al., 1983) . To investigate further the involvement of the adrenergic system in brain microvascular regulatory mechanisms in hypertension, we have measured aj-and « 2 -adrenergic receptors in the cerebral microvessels of normotensive and spontaneously hypertensive rats.
Methods
Male Sprague-Dawley rats weighing 200-300 g, adult (14-15-week-old) male spontaneously hypertensive rats (SHR), and age-matched Wistar-Kyoto control rats (WKY) were purchased from Charles River, Japan. Systolic blood pressure, measured by the tail cuff method, was 190 ± 5 mm Hg in SHR and 120 ± 3 mm Hg in WKY (means ± SEM, n = 7).
Brain microvessels were prepared as described previously (Kobayashi et al., 1981a) . In each experiment, 20-40 rats per group were used. Rats were killed by decapitation. Gray matter of cerebral cortices was rapidly cleaned from pial membrane and white matter, minced by scissors, and homogenized by hand in a Teflon-glass homogenizer in gassed (95% O 2 , 5% CO 2 ) Ringer's solution that consisted of 137 mM NaCl, 5 ITIM KC1, 3 ITIM CaCl^ 1.2 mM MgCl 2 , 12 mM NaHCO 3 , 5 mM glucose, 1% bovine serum albumin (BSA), and 15 mM HEPES (pH 7.4). The homogenate was passed through 700-, 200-, and 100-jzm nylon meshes and centrifuged at 1,000 g for 10 minutes. The pellet was suspended in the same solution, now containing 30% BSA, and centrifuged at 1,000 g for 15 minutes. The resulting small pellet was suspended in Ringer's solution. The floated thick layer was suspended in the supernatant and recentrifuged at 1,000 g for 15 minutes. The pellet was suspended in Ringer's solution and combined with the first suspension. The suspension was passed through a column of glass beads (0.2-0.5 mm in diameter) and washed extensively with Ringer's solution. The microvessels attached to the glass beads were released by gentle agitation in Ringer's solution, collected, and washed three times by centrifugation in the buffer used for binding assay.
ai-Adrenergic receptors were measured as described previously (Barnes et al., 1979; Kobayashi et al., 1982a Rouot and Snyder, 1979; Kobayashi et al., 1982a •y-Glutamyltranspeptidase (7-GTP), a marker enzyme of brain capillary, was measured according to the method of Orlowski and Meister (1965) , using •y-glutamyl-p-nitroanilide as a substrate. The samples were incubated in a reaction mixture composed of 5 ITIM L-7-glutamyl-p-nitroanilide, 10 mM MgCl^ and 100 mM Tris-HCl buffer (pH 9.0), in a final volume of 1 ml. After 60 minutes of incubation at 37°C, the reaction was terminated by the addition of 2 ml of 1.5 M acetic acid. The enzymatic reaction leads to the formation of p-nitroaniline which was determined by direct spectrophotometric measurement. The absorbance, at 410 nm, was recorded against a reference solution containing the same components except substrate.
Protein concentration was measured according to the method of Lowry et al. (1951) .
The maximum binding and the dissociation constant values of the specific binding of [
Results
The purity of the cerebral microvessls of SpragueDawley rats was checked by phase-contrast microscopy and by measurement of 7-glutamyltranspeptidase activity, and they were highly purified as described previously (Kobayashi et al., 1981a) .
The specific binding of [ HJprazosin to the cerebral microvessels was a linear function of amount of protein in the preparation up to 250 jig/tube (data not shown). A higher concentration of protein interfered with the binding assay by slowing the passage of the incubation medium through the filter.
The specific binding of [ (Fig. lb) .
The specific binding of [ (Fig. 3b) .
To characterize the stereospecificity of the binding sites, the inhibitory effect of /-or d-isomers of norepinephrine and epinephrine on [ The purity of the cerebral microvessel preparations from WKY and SHR was controlled by phasecontrast microscopy (Fig. 5) . The preparations were practically free from neuronal and glial elements. At this level of magnification, no morphological difference between the preparations from WKY and SHR is detectable. Table 2 shows that -y-GTP activities of WKY and SHR are comparable, both in the brain homogenate and in the microvessel preparation, y-GTP activity was more than 30 times higher in the microvessels than in the brain homogenate, indicating that both preparations were highly purified. There was no difference between WKY and SHR in recovery of the microvessels per unit of tissue weight. Figure 6a shows the specific binding of [ (Fig. 6b) shows that the B^* value for SHR is 50% higher than that of WKY, without a change in K D value: r w 43 ± 3 and 66 ± 5 fmol/mg protein (P < 0.01); K D , 81 + 5 and 83 ± 7 pM, for WKY and SHR, respectively. 
TABLE 1 Inhibition of [*H]Prazosln and [*H]PAC Binding by Adrenergic Agonists and Antagonists

Drugs
Discussion
Our data show the existence of ct\-and a 2 -adrenergic receptors in the rat cerebral microvessels which are labeled by [ Harik et al. (1980) reported the existence of /3-adrenergic receptors in the cerebral microvessels of the rat and pig, whereas they did not find the ai-adrenergic receptor sites by use of [ 3 H]-WB4101. However, Peroutka et al. (1980) demonstrated the presence of a considerable number of ai-receptor sites in the bovine cerebral microvessels, using the same radioligand, and we also reported the existence of «i-receptors which were labeled by [ 3 H]prazosin (Kobayashi et al., 1982a) . Characterization of the [ 3 H]prazosin-binding sites in this report ascertains the existence of the ai-adrenergic receptors in the cerebral microvessels. These results, together with reports of the existence of /3-adrenergic receptor sites (Kobayashi et al., 1981a (Kobayashi et al., , 1981b (Kobayashi et al., , 1982a Peroutka et al., 1980) and /3-adrenergic-sensitive adenylate cyclase activity (Herbst et al., 1979; Nathanson and Glaser, 1979) in the cerebral microvessels, are consistent with the hypothesis that functions of the brain microvessels are controlled by adrenergic innervation.
In a previous report, it was found that [ . In our system, the straight line in the Scatchard analysis showed that [ 3 H]PAC labeled a 2 -receptors of the cerebral microvessels with one affinity component, as in other tissues . Preskom et al. (1980) reported that tricyclic antidepressants, which are the blockers of the neuronal uptake of norepinephrine, increased the permeability for water from blood to the brain, and this bloodbrain permeability of water was decreased by the aadrenergic antagonist, phentolamine (Raichle et al., 1975) . These results suggest that a-receptors located on the cerebral microvessels are involved in the regulation of blood-brain barrier functions. (Magnoni et al., 1983) .
Morphological changes of the capillaries, such as increased diameter, endothelial cell degeneration, and deposition of collagen, were reported in experimental hypertensive animals and in humans with essential hypertension (Garcia et al., 1981) . Physiological experiments indicate that the acute elevation of systolic blood pressure induces a disruption of the blood-brain barrier, characterized by increased cerebral blood flow, extravasation of markers which normally do not pass the blood-brain barrier, and cerebral edema (Johansson et al., 1970 , Johansson, 1976 Heistad and Marcus, 1979) . Impaired capacity of cerebral blood flow autoregulation and cerebral edema also have been described in patients with severe hypertension (Byrom, 1954; Strangaard et al., 1975; Healton et al., 1982) .
In this report, we suggest the possibility that changes of ai-and /3-adrenergic receptors in the cerebral microvessels may be involved in the derangements of cerebral microvasculature observed in hypertension.
Catecholamines are implicated in the pathogenesis of hypertension. In fact, changes in the functions of peripheral adrenergic neurons and increased plasma catecholamine levels have been reported in hypertension, as well as alterations in the central nervous system (Reid et al., 1975; Lovemberg, 1976, 1977; Brody etal., 1980) . Synthesis, content, and turnover of catecholamines are modified in various brain regions of hypertensive rats (Nakamura et al., 1971 (Nakamura et al., a, 1971 Goldberg et al., 1975; Versteeg et al., 1976; Nagaoka et al., 1977; Gianutsos and Moore, 1978; Saavedra et al., 1978) , in concomitance with changes in adrenergic receptors (Cantor et al. ; Myers et al., 1981) . Alterations in hypertension of both central and peripheral adrenergic system may therefore concur in determining the changes of a-and ^-receptors in the brain capillaries.
It is interesting to note that the number of ai-and /3-adrenergic receptors is modified in opposite directions, indicating that the two populations may be independently regulated. Experimental observations show that a-and /3-receptors mediate opposite effects in cerebral microvasculature. /3-Receptor stimulation increases and a-receptor stimulation decreases cerebral blood flow and glucose uptake into the brain (Raichle et al., 1975; MacKenzie et al., 1976b; Schwarts, 1978; Abraham et al., 1979) . The same events have been described, in the rat auditory system (Savaki et al., 1978) . In this line, the higher level of cx\ -receptors and the reduced level of /9-receptors in the cerebral microvessels of hypertensive rats could produce the same functional changes in response to catecholamine system. These events may be the consequence of specific changes in neuronal regulatory mechanisms of cerebral microvasculature induced by hypertension.
